[144] Mind Medicine (MindMed) Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Mind Medicine (MNMD): The filing records a proposed sale of 25,797 common shares with an aggregate market value of $252,106.34 through Morgan Stanley Smith Barney LLC on 09/25/2025 on Nasdaq. The shares were acquired the same day as restricted stock vesting under a registered plan and payment is listed as Not Applicable. The form also discloses a prior sale by Robert B Barrow of 26,491 shares on 06/25/2025 for gross proceeds of $180,210.33. The filer attests there is no undisclosed material adverse information and the standard signature and legal warning language appear.

Insights

Financial Analyst

TL;DR: Insider sale appears routine: vested restricted shares sold through broker; transaction size is modest.

The transaction is an internal liquidity event arising from restricted stock vesting, with 25,797 shares valued at $252,106.34 scheduled for sale on 09/25/2025 via Morgan Stanley Smith Barney LLC on Nasdaq. The filing indicates acquisition and sale on the same date under a registered plan, suggesting compliance with resale conditions. A prior sale by Robert B Barrow of 26,491 shares on 06/25/2025 for $180,210.33 is separately disclosed. Absent additional context on outstanding float or executive role, this filing alone is a routine insider liquidity disclosure.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 mechanics; vesting-driven sale and attestation included, consistent with required compliance.

The form documents that the shares to be sold were acquired via restricted stock vesting under a registered plan and that the filer affirms no undisclosed material adverse information. The broker, sale date, share count, and market value are provided, and the filing includes the required attestation and legal certification language. From a governance perspective, the filing meets procedural requirements for Rule 144 notices but does not supply issuer details within the form text itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25797	252106.34	76087943	09/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/25/2025	Restricted stock vesting under a registered plan	Issuer			25797	09/25/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT B BARROW One World Trade Center, Suite 8500 New York NY 10007	Common	06/25/2025	26491	180210.33

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)